Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery

Kortnye Smith; Sophie O’Haire; Benjamin Markman; Hui Gan; Kenneth J. O’Byrne; Michael Millward; Ben Tran; Benjamin Solomon; Clare L. Scott; Damien Kee; Grant A. McArthur; Andrew Fellowes; Dong Anh K. Khoung-Quang; Paul G. Ekert; Paul A. James; Huiling Xu; Melissa Martyn; Elly Lynch; Rona Weerasuriya; Clara Gaff; Stephen B. Fox; Jayesh Desai

doi:10.1200/po.23.00247

Abstract

Despite increasing evidence of benefit supporting complex genomic sequencing (CGS) in personalizing cancer therapy, its widespread uptake remains limited.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Smith et al. (2024) studied this question.

synapsesocial.com/papers/68e5e2bfb6db6435875775b4 https://doi.org/10.1200/po.23.00247

View Full Paper

Ask AI

Bookmark

Share

Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery

Abstract

Discussion

Cite This Study

Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery

Abstract

Discussion

Cite This Study

Keep reading

Keep reading